ADME-Toxicology Testing

Global Market Trajectory & Analytics

MCP-7635

EXECUTIVE ENGAGEMENTS

POOL

3707
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

667
Interactions with Platform & by Email

PARTICIPANTS

111
Unique # Participated

VALIDATIONS

32
Responses Validated*

COMPANIES

69
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

306

PAGES

405

EDITION

16

PRICE

USD 5600

CODE

MCP-7635


COMPETITIVE METRICS

COMPANY

D S N T

% *

AB Sciex LLC

Login Required

ACEA Biosciences, Inc.

Login Required

ADMEcell, Inc.

Login Required

Advanced Chemistry Development, Inc. (ACD/Labs)

Login Required

Agena Bioscience, Inc.

Login Required

Agilent Technologies, Inc.

Login Required

Albany Molecular Research, Inc.

Login Required

BD Biosciences

Login Required

Bio-Rad Laboratories, Inc.

Login Required

BioReliance Corporation

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 69 COMPETITORS

Sign-in with email to View Deeper Validated Engagement Details -

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for ADME-Toxicology Testing estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$10.2 Billion by 2027, growing at a CAGR of 10.1% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$4.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the High Throughput segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The ADME-Toxicology Testing market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 13.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 8.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
In the global Molecular Imaging segment, USA, Canada, Japan, China and Europe will drive the 9.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$860.6 Million in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 11.2% CAGR through the analysis period.

SELECT PLAYERS

ACEA Biosciences Inc.; ADMEcell Inc.; Agilent Technologies, Inc.; Albany Molecular Research Inc.; Beckman Coulter Inc.; CompuDrug International Inc.; Cyprotex PLC.; Dassault Systèmes Biovia Corp.; Eurofins ADME BIOANALYSES SAS; Galapagos NV; Molecular Discovery Ltd.; MultiCASE Inc.; Optivia Biotechnology; PerkinElmer Inc.; Promega Corporation; Simulations Plus Inc.; Takara Bio Europe AB; Tecan Group Ltd.; Thermo Fischer Scientific Inc.

SEGMENTS

» Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology) » Method (Cellular Assay, Biochemical Assay, Ex-vivo, In Silica) » Application (Systemic Toxicity, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
ADME-Tox Testing Gains Traction
Recent Market Activity
A Peek into the Impact of ADME-Tox Screening on New Drug Discovery
Current and Future Analysis
US and Europe Dominate, Asia-Pacific Lends Growth Momentum
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
Pharma Industry Renews Focus on Cost Optimization
China and India: Hot Spots for R&D Investment
ADME-Tox Assays - An Overview
Introduction of Early In Vitro ADMET Studies
Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
Major Types of Cell-Based HTS Assays for Drug Screening
CROs Expand Presence
Drug Discovery Outsourcing and Type of Services Outsourced
Changing Face of Drug Discovery Outsourcing Activity
M&A - Order of the Day
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ACEA Biosciences, Inc. (USA)
ADMEcell, Inc. (USA)
Agilent Technologies, Inc. (USA)
Albany Molecular Research, Inc. (USA)
Beckman Coulter, Inc. (USA)
BioreclamationIVT, LLC (USA)
Cerep SA (France)
CompuDrug International, Inc. (USA)
Cyprotex PLC. (UK)
CeeTox, Inc. (USA)
Dassault Systèmes Biovia Corp. (USA)
Eurofins ADME BIOANALYSES SAS (France)
Galapagos NV (Belgium)
Molecular Discovery Ltd. (UK)
MultiCASE, Inc. (USA)
Optivia Biotechnology (USA)
PerkinElmer, Inc. (USA)
Pharmaron, Inc. (USA)
Promega Corporation (USA)
Qualyst, Inc. (USA)
Simulations Plus, Inc. (USA)
Taconic Biosciences, Inc. (USA)
Takara Bio Europe AB (Sweden)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Current State of ADME-Tox Testing
Need for Better Models: A Major Factor Driving Innovation in the Market
Focus Shifts to Innovative Approaches
In Silico and In Vitro- the Way to Go
In Vitro Testing Systems and Its Relevance in Drug Development
Growing Inclination towards In-vitro Assays for Toxicology Studies
In Silico ADME-Tox Growing at a Fast Clip
Advantages of Using In Silico Approaches
Factors Hindering Growth
3-D Tissue Bioassays to Enhance In Vitro Toxicity Testing
Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
Rising Number of Drug Targets Surge Demand for Cell-Based Assays
Growing Focus on the Development of Reproducible and Robust Cell-based Assays
Functional Assays: An Effective Way of Predicting Specific Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
New Alternatives for Early-Stage Toxicology Testing
Stem Cells Exude Great Potential in Drug Toxicity Testing
Primary Hepatocytes Become Standard Tool for Evaluation in Hepatic Metabolism
Improved Cryopreservation Technologies Help Expand Use of Hepatocytes
Cardiotoxicity Testing Gains Prominence
Cell Imaging-Gaining Popularity
In Vivo Imaging Persists in ADME-Tox Testing
Computational Models on Rise
Adoption of Data Management Systems
Drug Transporter Analysis Becoming Part of ADME Assessment
Slow Metabolism of Novel Drugs Call for More Human Models in Screening
Further Advances Required for More Understanding of Biotransformation
Introduction of Third Dimension in Cell Culturing Drives Need for New Instrumentation
Regulatory Bodies Focus on Transporter Mediated DDIs
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for High Throughput by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for High Throughput by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for High Throughput by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for OMICS Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for OMICS Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for OMICS Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Ex-vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ex-vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ex-vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
USA Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
USA Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
China Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
China Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
France Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
France Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
UK Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
UK Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
India Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
India Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 69

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com